
Aragen Integrated Drug Discovery (AIDD) platform brings together the strength of our in-house drug discovery capabilities, data science and structural biology/crystallography with a strong focus on efficiency, accuracy and savings.
In-house Drug Discovery Capabilities
Concept to Proof-of-Concept
Structural Biology, Crystallography and Library Screening*
With our strategic PROTEROS and Nanoimaging partnership
Computational Biology
& Data Science
Target Identification & validation
What we bring:
We have implemented a proprietary digital platform InCoRe for Design-Make-Test-Analyze’ (DMTA) cycle and compound data management system (CDMS) for effective project management.
CDMS is designed to have an integrated digital process platform from compound registration to assay results and data storage for analysis. IDD’s partners can directly monitor the projects in real time and make compound assay requests directly from partner’s location.
This platform is an integration of digital tools as well as customised automated platforms for data acquisition, data transfer and data analysis. It is the integrated discovery workflow for CADD-Medchem-Biology-DMPK that ensures easy tracking, smooth data transfer and clear visualization across the various project stake holders.